BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia
This article will focus on the treatment approach of CLL patients with BCl2 antag onists. Treatment strategy (combined versus monotherapy; continuous versus limited duration therapy), toxicity profile, and future directions will be exposed in this review.
Source: Current Treatment Options in Oncology - Category: Cancer & Oncology Source Type: research
More News: Biology | Cancer & Oncology | Chemotherapy | Chronic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukaemia | Fish | Genetics | Gleevec | Hematology | Immunotherapy | Leukemia | Mitochondrial Disease | Molecular Biology | Rituxan | Toxicology | Treanda